U.S. Panel Recommends Limiting Gene Therapy Trials (HealthD
HealthDay - SATURDAY, March 5 (HealthDay News) -- Federal health advisers recommended late Friday that two U.S. gene therapy trials for children with a severe immune deficiency resume but on a very limited basis.
Read more...